1832 Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

1832 Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-157	Closed	-$21K	–	889
2021 Q2	$21K	Sell	157 -3,255	-95%	-$428K	﹤0.01%	663
2021 Q1	$446K	Sell	3,412 -105	-3%	-$15.7K	﹤0.01%	486
2020 Q4	$508K	Sell	3,517 -661	-16%	-$84.7K	﹤0.01%	534
2020 Q3	$470K	Buy	4,178 +1,535	+58%	+$172K	﹤0.01%	511
2020 Q2	$294K	Buy	+2,643	New	+$260K	﹤0.01%	515
2020 Q1	–	Sell	-5,211	Closed	-$497K	–	770
2019 Q4	$497K	Buy	5,211 +4,148	+390%	+$359K	﹤0.01%	472
2019 Q3	$81K	Hold	1,063	–	–	﹤0.01%	551
2019 Q2	$93K	Hold	1,063	–	–	﹤0.01%	560
2019 Q1	$93K	Hold	1,063	–	–	﹤0.01%	489
2018 Q4	$77K	Hold	1,063	–	–	﹤0.01%	473
2018 Q3	$102K	Sell	1,063 -17,746	-94%	-$1.72M	﹤0.01%	525
2018 Q2	$1.79M	Sell	18,809 -1,039	-5%	-$95.5K	0.01%	386
2018 Q1	$1.75M	Sell	19,848 -1,568	-7%	-$143K	0.01%	378
2017 Q4	$1.81M	Buy	21,416 +6,160	+40%	+$516K	0.01%	379
2017 Q3	$1.28M	Hold	15,256	–	–	﹤0.01%	406
2017 Q2	$1.18M	Sell	15,256 -39,489	-72%	-$2.8M	0.01%	422
2017 Q1	$3.8M	Buy	+54,745	New	+$3.68M	0.01%	355

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

1832 Asset Management's XBI Position: Q3 2021 in Review

1832 Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 157 shares — an estimated $21K sold.

1832 Asset Management first reported a position in XBI in Q1 2017 and held it in 17 quarters. The position peaked at $3.8M in Q1 2017. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

1832 Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
1832 Asset Management sold 157 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $21K.
1832 Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 17 quarters.
1832 Asset Management's State Street SPDR S&P Biotech ETF position peaked at $3.8M in Q1 2017.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on 1832 Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.